These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 16528036)

  • 1. Antiviral effect of alpha-glucosidase inhibitors on viral morphogenesis and binding properties of hepatitis C virus-like particles.
    Chapel C; Garcia C; Roingeard P; Zitzmann N; Dubuisson J; Dwek RA; Trépo C; Zoulim F; Durantel D
    J Gen Virol; 2006 Apr; 87(Pt 4):861-871. PubMed ID: 16528036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Affect of deoxynojirimycin derivatives on hepatitis C virus morphogenesis].
    Timokhova AV; Bakinovskiĭ LV; Zinin AI; Popenko VI; Ivanov AV; Rubtsov PM; Kochetkov SN; Belzhelarskaia SN
    Mol Biol (Mosk); 2012; 46(4):644-53. PubMed ID: 23113354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of the infectivity of hepatitis C virus pseudoparticles by incorporation of misfolded glycoproteins induced by glucosidase inhibitors.
    Chapel C; Garcia C; Bartosch B; Roingeard P; Zitzmann N; Cosset FL; Dubuisson J; Dwek RA; Trépo C; Zoulim F; Durantel D
    J Gen Virol; 2007 Apr; 88(Pt 4):1133-1143. PubMed ID: 17374756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imino sugars inhibit the formation and secretion of bovine viral diarrhea virus, a pestivirus model of hepatitis C virus: implications for the development of broad spectrum anti-hepatitis virus agents.
    Zitzmann N; Mehta AS; Carrouée S; Butters TD; Platt FM; McCauley J; Blumberg BS; Dwek RA; Block TM
    Proc Natl Acad Sci U S A; 1999 Oct; 96(21):11878-82. PubMed ID: 10518544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitors of endoplasmic reticulum alpha-glucosidases potently suppress hepatitis C virus virion assembly and release.
    Qu X; Pan X; Weidner J; Yu W; Alonzi D; Xu X; Butters T; Block T; Guo JT; Chang J
    Antimicrob Agents Chemother; 2011 Mar; 55(3):1036-44. PubMed ID: 21173177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral therapies targeting host ER alpha-glucosidases: current status and future directions.
    Chang J; Block TM; Guo JT
    Antiviral Res; 2013 Sep; 99(3):251-60. PubMed ID: 23816430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha-glucosidase inhibitors as potential broad based anti-viral agents.
    Mehta A; Zitzmann N; Rudd PM; Block TM; Dwek RA
    FEBS Lett; 1998 Jun; 430(1-2):17-22. PubMed ID: 9678587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Action of celgosivir (6 O-butanoyl castanospermine) against the pestivirus BVDV: implications for the treatment of hepatitis C.
    Whitby K; Taylor D; Patel D; Ahmed P; Tyms AS
    Antivir Chem Chemother; 2004 May; 15(3):141-51. PubMed ID: 15266896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel imino sugar α-glucosidase inhibitors as antiviral compounds.
    Howe JD; Smith N; Lee MJ; Ardes-Guisot N; Vauzeilles B; Désiré J; Baron A; Blériot Y; Sollogoub M; Alonzi DS; Butters TD
    Bioorg Med Chem; 2013 Aug; 21(16):4831-8. PubMed ID: 23582447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucosidase inhibitors as antiviral agents for hepatitis B and C.
    Durantel D; Alotte C; Zoulim F
    Curr Opin Investig Drugs; 2007 Feb; 8(2):125-9. PubMed ID: 17328228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Characterization of hepatitis C virus structural proteins and HCV-like particles produced in recombinant baculovirus infected insect cells].
    Belzhelarskaia SN; Koroleva NN; Popenko VV; Drutsa VL; Orlova OV; Rubtsov PM; Kochetkov SN
    Mol Biol (Mosk); 2010; 44(1):107-19. PubMed ID: 20198865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiviral effect of N-butyldeoxynojirimycin against bovine viral diarrhea virus correlates with misfolding of E2 envelope proteins and impairment of their association into E1-E2 heterodimers.
    Branza-Nichita N; Durantel D; Carrouée-Durantel S; Dwek RA; Zitzmann N
    J Virol; 2001 Apr; 75(8):3527-36. PubMed ID: 11264342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of functional hepatitis C virus envelope glycoproteins.
    Op De Beeck A; Voisset C; Bartosch B; Ciczora Y; Cocquerel L; Keck Z; Foung S; Cosset FL; Dubuisson J
    J Virol; 2004 Mar; 78(6):2994-3002. PubMed ID: 14990718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The combination of interferon alpha-2b and n-butyl deoxynojirimycin has a greater than additive antiviral effect upon production of infectious bovine viral diarrhea virus (BVDV) in vitro: implications for hepatitis C virus (HCV) therapy.
    Ouzounov S; Mehta A; Dwek RA; Block TM; Jordan R
    Antiviral Res; 2002 Sep; 55(3):425-35. PubMed ID: 12206880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of hepatitis B virus-infected cells with alpha-glucosidase inhibitors results in production of virions with altered molecular composition and infectivity.
    Lazar C; Durantel D; Macovei A; Zitzmann N; Zoulim F; Dwek RA; Branza-Nichita N
    Antiviral Res; 2007 Oct; 76(1):30-7. PubMed ID: 17548120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A strategy for anti-viral intervention: the use of alpha-glucosidase inhibitors to prevent chaperone-mediated folding of viral envelope glycoproteins.
    Mehta A; Rudd PM; Block TM; Dwek RA
    Biochem Soc Trans; 1997 Nov; 25(4):1188-93. PubMed ID: 9449973
    [No Abstract]   [Full Text] [Related]  

  • 17. alpha-Glucosidase inhibitors have a prolonged antiviral effect against hepatitis B virus through the sustained inhibition of the large and middle envelope glycoproteins.
    Simsek E; Lu X; Ouzounov S; Block TM; Mehta AS
    Antivir Chem Chemother; 2006; 17(5):259-67. PubMed ID: 17176630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha-glucosidase inhibitors reduce dengue virus production by affecting the initial steps of virion morphogenesis in the endoplasmic reticulum.
    Courageot MP; Frenkiel MP; Dos Santos CD; Deubel V; Desprès P
    J Virol; 2000 Jan; 74(1):564-72. PubMed ID: 10590151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant hepatitis C virus-like particles expressed by baculovirus: utility in cell-binding and antibody detection assays.
    Xiang J; Wünschmann S; George SL; Klinzman D; Schmidt WN; LaBrecque DR; Stapleton JT
    J Med Virol; 2002 Dec; 68(4):537-43. PubMed ID: 12376962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the endoplasmic reticulum-associated degradation (ERAD) pathway in degradation of hepatitis C virus envelope proteins and production of virus particles.
    Saeed M; Suzuki R; Watanabe N; Masaki T; Tomonaga M; Muhammad A; Kato T; Matsuura Y; Watanabe H; Wakita T; Suzuki T
    J Biol Chem; 2011 Oct; 286(43):37264-73. PubMed ID: 21878646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.